nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adhesion-mediated apoptosis resistance in cancer
|
Westhoff, Mike-Andrew |
|
2009 |
|
4-5 |
p. 127-136 10 p. |
artikel |
2 |
Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma
|
Broxterman, Henk J. |
|
2007 |
|
4-5 |
p. 182-193 12 p. |
artikel |
3 |
Artemisinins: mechanisms of action and potential for resistance
|
Krishna, Sanjeev |
|
2004 |
|
4-5 |
p. 233-244 12 p. |
artikel |
4 |
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy
|
Moretti, Luigi |
|
2007 |
|
4-5 |
p. 135-143 9 p. |
artikel |
5 |
Candida biofilm resistance
|
Mukherjee, Pranab K. |
|
2004 |
|
4-5 |
p. 301-309 9 p. |
artikel |
6 |
Editorial Board
|
|
|
2009 |
|
4-5 |
p. i- 1 p. |
artikel |
7 |
Editorial Board
|
|
|
2006 |
|
4-5 |
p. i- 1 p. |
artikel |
8 |
Editorial Board
|
|
|
2004 |
|
4-5 |
p. i- 1 p. |
artikel |
9 |
Editorial Board
|
|
|
2007 |
|
4-5 |
p. i- 1 p. |
artikel |
10 |
Editorial Board
|
|
|
2008 |
|
4-5 |
p. i- 1 p. |
artikel |
11 |
Editorial Board
|
|
|
2010 |
|
4-5 |
p. i- 1 p. |
artikel |
12 |
Editorial Board
|
|
|
2011 |
|
4-5 |
p. i- 1 p. |
artikel |
13 |
Epidemiology and characteristics of antimicrobial resistance in China
|
Xiao, Yong-Hong |
|
2011 |
|
4-5 |
p. 236-250 15 p. |
artikel |
14 |
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker
|
Teodoridis, Jens M. |
|
2004 |
|
4-5 |
p. 267-278 12 p. |
artikel |
15 |
Leishmaniasis: drugs in the clinic, resistance and new developments
|
Ouellette, Marc |
|
2004 |
|
4-5 |
p. 257-266 10 p. |
artikel |
16 |
Literature Highlights: Recent research in infectious disease drug resistance
|
|
|
2006 |
|
4-5 |
p. 247-258 12 p. |
artikel |
17 |
Literature highlights: Recent research in infectious disease drug resistance
|
|
|
2007 |
|
4-5 |
p. 194-204 11 p. |
artikel |
18 |
Literature highlights: recent research in infectious disease drup resistance
|
|
|
2004 |
|
4-5 |
p. 311-315 5 p. |
artikel |
19 |
Mechanisms of proteasome inhibitor action and resistance in cancer
|
McConkey, David J. |
|
2008 |
|
4-5 |
p. 164-179 16 p. |
artikel |
20 |
Meetings Calendar
|
|
|
2009 |
|
4-5 |
p. 137-139 3 p. |
artikel |
21 |
Meetings Calendar
|
|
|
2006 |
|
4-5 |
p. 259-261 3 p. |
artikel |
22 |
Meetings Calendar
|
|
|
2007 |
|
4-5 |
p. 205-206 2 p. |
artikel |
23 |
Meetings Calendar
|
|
|
2008 |
|
4-5 |
p. 200-203 4 p. |
artikel |
24 |
Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine
|
Anderson, Judy E. |
|
2006 |
|
4-5 |
p. 198-210 13 p. |
artikel |
25 |
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
|
Schmidt, Mathias |
|
2007 |
|
4-5 |
p. 162-181 20 p. |
artikel |
26 |
Molecular mechanisms of platinum resistance: still searching for the Achilles’ heel
|
Wernyj, Roman P. |
|
2004 |
|
4-5 |
p. 227-232 6 p. |
artikel |
27 |
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
|
Sabbah, Michèle |
|
2008 |
|
4-5 |
p. 123-151 29 p. |
artikel |
28 |
Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies
|
Magagnin, Michaël G. |
|
2006 |
|
4-5 |
p. 185-197 13 p. |
artikel |
29 |
Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling
|
Alaoui-Jamali, Moulay A. |
|
2004 |
|
4-5 |
p. 245-255 11 p. |
artikel |
30 |
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum
|
van Schalkwyk, Donelly A. |
|
2006 |
|
4-5 |
p. 211-226 16 p. |
artikel |
31 |
Recent research in infectious disease drug resistance
|
|
|
2008 |
|
4-5 |
p. 180-199 20 p. |
artikel |
32 |
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
|
Vazquez-Martin, Alejandro |
|
2011 |
|
4-5 |
p. 212-223 12 p. |
artikel |
33 |
Resistance to HIV-1 integrase inhibitors: A structural perspective
|
Mouscadet, Jean-François |
|
2010 |
|
4-5 |
p. 139-150 12 p. |
artikel |
34 |
Resistance to polymyxins: Mechanisms, frequency and treatment options
|
Falagas, Matthew E. |
|
2010 |
|
4-5 |
p. 132-138 7 p. |
artikel |
35 |
Roots of imatinib resistance: A question of self-renewal?
|
Burchert, Andreas |
|
2007 |
|
4-5 |
p. 152-161 10 p. |
artikel |
36 |
Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future
|
Giske, Christian G. |
|
2010 |
|
4-5 |
p. 93-98 6 p. |
artikel |
37 |
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
|
Wang, Zhiwei |
|
2010 |
|
4-5 |
p. 109-118 10 p. |
artikel |
38 |
The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer
|
Kono, Scott A. |
|
2009 |
|
4-5 |
p. 95-102 8 p. |
artikel |
39 |
The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms
|
Isaac, Methvin |
|
2011 |
|
4-5 |
p. 203-211 9 p. |
artikel |
40 |
Therapeutic prospects for p73 and p63: Rising from the shadow of p53
|
Vilgelm, Anna |
|
2008 |
|
4-5 |
p. 152-163 12 p. |
artikel |
41 |
Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches
|
Konopleva, Marina |
|
2009 |
|
4-5 |
p. 103-113 11 p. |
artikel |
42 |
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
|
Assaraf, Yehuda G. |
|
2006 |
|
4-5 |
p. 227-246 20 p. |
artikel |
43 |
The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches
|
Lacerda, Lara |
|
2010 |
|
4-5 |
p. 99-108 10 p. |
artikel |
44 |
Tissue transglutaminase-mediated chemoresistance in cancer cells
|
Verma, Amit |
|
2007 |
|
4-5 |
p. 144-151 8 p. |
artikel |
45 |
Translating DNA damage into cancer cell death—A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
|
Engelmann, David |
|
2010 |
|
4-5 |
p. 119-131 13 p. |
artikel |
46 |
Translational imaging endpoints to predict treatment response to novel targeted anticancer agents
|
Serkova, Natalie J. |
|
2011 |
|
4-5 |
p. 224-235 12 p. |
artikel |
47 |
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
|
Broxterman, Henk J. |
|
2009 |
|
4-5 |
p. 114-126 13 p. |
artikel |
48 |
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
|
Glade Bender, Julia |
|
2004 |
|
4-5 |
p. 289-300 12 p. |
artikel |
49 |
Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies
|
Laufer, Miriam K. |
|
2004 |
|
4-5 |
p. 279-288 10 p. |
artikel |